Cellseed Inc. | Balance Sheet

Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
2,689
2,921
2,068
1,056
1,350
Total Accounts Receivable
10
18
27
154
82
Inventories
15
28
22
33
23
Other Current Assets
34
51
67
16
22
Total Current Assets
2,748
3,018
2,183
1,259
1,477
Net Property, Plant & Equipment
-
-
246
22
22
Intangible Assets
-
-
-
-
1
Other Assets
37
33
61
62
62
Total Assets
2,785
3,051
2,490
1,344
1,562
Accounts Payable
1
2
6
6
6
Income Tax Payable
20
14
1
6
14
Other Current Liabilities
228
218
93
164
283
Total Current Liabilities
248
234
100
176
303
Other Liabilities
-
-
-
3
-
Total Liabilities
248
234
100
179
303
Common Equity (Total)
2,536
2,817
2,390
1,164
1,259
Total Shareholders' Equity
2,536
2,817
2,390
1,164
1,259
Total Equity
2,536
2,817
2,390
1,164
1,259
Liabilities & Shareholders' Equity
2,785
3,051
2,490
1,344
1,562

About Cellseed

View Profile
Address
Telecom Center Building, 15/F
Tokyo Tokyo 135
Japan
Employees -
Website http://www.cellseed.com
Updated 09/14/2018
CellSeed Inc. develops regenerative medicine products. Its operations are carried out through the following business divisions: Cell Sheet Regenerative Medicine and Intelligent Cell Culture Ware Products. The Cell Sheet Regenerative Medicine division provides research, development, marketing, and sale of epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.